Wolters Kluwer Announces Partnership with the FNCP to Improve Clinical Decision-Making in Spain

Wolters KluwerWolters Kluwer, a leading global provider of information for healthcare professionals and students, has announced a new partnership with the Federación Nacional de Clínicas Privadas (FNCP), an organization representing over 550 of the private healthcare institutions in Spain.

The collaboration reflects Wolters Kluwer's focus on fostering growth in the Spanish market and broadening adoption of UpToDate®, the clinical decision support resource used by more than 1 million doctors worldwide. The partnership supports a common mission of the FNCP and Wolters Kluwer to improve care in hospitals and clinics across the country.

Carlos Rus, managing director of FNCP, commented that it is essential to support "any option to improve patient care and promote excellence in healthcare. For the FNCP, it is very important to offer our members services like this, that can bring agility, information, knowledge, safety and quality, to both managers and health centers as well as patients themselves."

As the FNCP strategically focuses on ensuring a higher quality of care and better health outcomes, UpToDate helps member institutions realize these goals by equipping clinicians with access to the most current clinical recommendations to make the best decisions for patients. Working with the FNCP also complements access to UpToDate currently available at over 300 healthcare sites in the Sistema Nacional de Salud (SNS), Spain's national health system operated by Spain's Ministry of Health, Social Services and Equality.

"UpToDate provides clinicians throughout Spain with evidence-based recommendations to make better care decisions for their patients," says Denise Basow, MD, Vice President and General Manager, UpToDate at Wolters Kluwer, Clinical Solutions. "Our partnership with the FNCP forms an important part of our mission to improve the quality and effectiveness of healthcare throughout Spain."

About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...